Quantitative imaging of protein targets in the human brain with PET
暂无分享,去创建一个
Mark Slifstein | Roger N Gunn | Graham E Searle | Julie C Price | J. Price | G. Searle | R. Gunn | M. Slifstein | J. Price | J. Price
[1] E. Hansson,et al. Astrocyte–endothelial interactions at the blood–brain barrier , 2006, Nature Reviews Neuroscience.
[2] T. Jones,et al. Spectral Analysis of Dynamic PET Studies , 1993, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[3] Xiao Jin,et al. Evaluation of Frame-Based and Event-by-Event Motion-Correction Methods for Awake Monkey Brain PET Imaging , 2014, The Journal of Nuclear Medicine.
[4] R. Frackowiak,et al. Monitoring by PET of macrophage accumulation in brain after ischaemic stroke , 1992, The Lancet.
[5] M. Nedergaard,et al. The blood–brain barrier: an overview Structure, regulation, and clinical implications , 2004, Neurobiology of Disease.
[6] Roger N Gunn,et al. Characterising the plasma-target occupancy relationship of the neurokinin antagonist GSK1144814 with PET , 2014, Journal of psychopharmacology.
[7] B. Lopresti,et al. The peripheral benzodiazepine receptor (Translocator protein 18kDa) in microglia: From pathology to imaging , 2006, Progress in Neurobiology.
[8] Richard E. Carson,et al. Comment: The EM Parametric Image Reconstruction Algorithm , 1985 .
[9] B. Tavitian,et al. Current paradigm of the 18-kDa translocator protein (TSPO) as a molecular target for PET imaging in neuroinflammation and neurodegenerative diseases , 2011, Insights into Imaging.
[10] N. Volkow,et al. Neuropharmacological actions of cigarette smoke: brain monoamine oxidase B (MAO B) inhibition. , 1998, Journal of addictive diseases.
[11] David Goldman,et al. Effect of a triallelic functional polymorphism of the serotonin-transporter-linked promoter region on expression of serotonin transporter in the human brain. , 2006, The American journal of psychiatry.
[12] G. Ecker,et al. Development of potential selective and reversible pyrazoline based MAO-B inhibitors as MAO-B PET tracer precursors and reference substances for the early detection of Alzheimer's disease. , 2014, Bioorganic & medicinal chemistry letters.
[13] Ciprian Catana,et al. MRI-Assisted PET Motion Correction for Neurologic Studies in an Integrated MR-PET Scanner , 2011, The Journal of Nuclear Medicine.
[14] Victoria Arango,et al. Regional Heterogeneity of 5-HT1A Receptors in Human Cerebellum as Assessed by Positron Emission Tomography , 2005, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[15] Alan A. Wilson,et al. Translocator Protein (18 kDa) Polymorphism (rs6971) Explains in-vivo Brain Binding Affinity of the PET Radioligand [18F]-FEPPA , 2012, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[16] Roger N Gunn,et al. Positron Emission Tomography Compartmental Models: A Basis Pursuit Strategy for Kinetic Modeling , 2002, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[17] L. Marner,et al. Age and sex effects on 5-HT4 receptors in the human brain: A [11C]SB207145 PET study , 2011, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[18] W. Jusko,et al. Pharmacokinetics of Capacity‐Limited Systems , 1989, Journal of clinical pharmacology.
[19] H. N. Wagner,et al. Multicompartmental Analysis of [11C]-Carfentanil Binding to Opiate Receptors in Humans Measured by Positron Emission Tomography , 1989, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[20] Mark Slifstein,et al. Measurement of the Proportion of D2 Receptors Configured in State of High Affinity for Agonists in Vivo: A Positron Emission Tomography Study Using [11C]N-Propyl-norapomorphine and [11C]Raclopride in Baboons , 2005, Journal of Pharmacology and Experimental Therapeutics.
[21] Robert B. Innis,et al. Kinetic analysis in healthy humans of a novel positron emission tomography radioligand to image the peripheral benzodiazepine receptor, a potential biomarker for inflammation , 2008, NeuroImage.
[22] D L Hill,et al. Automated three-dimensional registration of magnetic resonance and positron emission tomography brain images by multiresolution optimization of voxel similarity measures. , 1997, Medical physics.
[23] R. Upadhyay. Drug Delivery Systems, CNS Protection, and the Blood Brain Barrier , 2014, BioMed research international.
[24] J C Mazziotta,et al. Modelling approach for separating blood time-activity curves in positron emission tomographic studies. , 1991, Physics in medicine and biology.
[25] Guy Marchal,et al. Multimodality image registration by maximization of mutual information , 1997, IEEE Transactions on Medical Imaging.
[26] Alan A. Wilson,et al. Neuroinflammation in healthy aging: A PET study using a novel Translocator Protein 18kDa (TSPO) radioligand, [18F]-FEPPA , 2014, NeuroImage.
[27] Sylvain Houle,et al. High-Affinity States of Human Brain Dopamine D2/3 Receptors Imaged by the Agonist [11C]-(+)-PHNO , 2006, Biological Psychiatry.
[28] Juha Koikkalainen,et al. Fast and robust multi-atlas segmentation of brain magnetic resonance images , 2010, NeuroImage.
[29] K. Herholz,et al. Brain receptor imaging. , 2010, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[30] Kewei Chen,et al. Image-Derived Input Function for Brain PET Studies: Many Challenges and Few Opportunities , 2011, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[31] J. Dalley,et al. Applications of positron emission tomography in animal models of neurological and neuropsychiatric disorders , 2012, Neuroscience & Biobehavioral Reviews.
[32] Ming-Rong Zhang,et al. PET applications in animal models of neurodegenerative and neuroinflammatory disorders. , 2012, Current topics in behavioral neurosciences.
[33] M. Folstein,et al. EFFECTS OF AGE ON DOPAMINE AND SEROTONIN RECEPTORS MEASURED BY POSITRON TOMOGRAPHY IN THE LIVING HUMAN BRAIN , 1984, Science.
[34] W. Klunk,et al. Impact of amyloid imaging on drug development in Alzheimer's disease. , 2007, Nuclear medicine and biology.
[35] Jeih-San Liow,et al. D2 dopamine receptor internalization prolongs the decrease of radioligand binding after amphetamine: A PET study in a receptor internalization-deficient mouse model , 2010, NeuroImage.
[36] Jeih-San Liow,et al. Quantitation of cannabinoid CB1 receptors in healthy human brain using positron emission tomography and an inverse agonist radioligand , 2009, NeuroImage.
[37] Lisa A. Weissfeld,et al. Inter-rater reliability of manual and automated region-of-interest delineation for PiB PET , 2010, NeuroImage.
[38] Patrick Dupont,et al. Evaluation of anatomy based reconstruction for partial volume correction in brain FDG-PET , 2004, NeuroImage.
[39] W. Klunk,et al. Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B , 2004, Annals of neurology.
[40] J. Trojanowski,et al. Advances in tau-focused drug discovery for Alzheimer's disease and related tauopathies , 2009, Nature Reviews Drug Discovery.
[41] J. Logan. Graphical analysis of PET data applied to reversible and irreversible tracers. , 1999, Nuclear medicine and biology.
[42] Richard E Carson,et al. Noise Reduction in the Simplified Reference Tissue Model for Neuroreceptor Functional Imaging , 2002, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[43] D. Marquardt. An Algorithm for Least-Squares Estimation of Nonlinear Parameters , 1963 .
[44] G. Schwarz. Estimating the Dimension of a Model , 1978 .
[45] John D. Beaver,et al. Mathematical modelling of [11C]-(+)-PHNO human competition studies , 2013, NeuroImage.
[46] Sung-Cheng Huang,et al. Linear regression with spatial constraint to generate parametric images of ligand-receptor dynamic PET studies with a simplified reference tissue model , 2003, NeuroImage.
[47] Jeih-San Liow,et al. Downregulation of Brain Phosphodiesterase Type IV Measured with 11C-(R)-Rolipram Positron Emission Tomography in Major Depressive Disorder , 2012, Biological Psychiatry.
[48] E. Hoffman,et al. Quantitation in Positron Emission Computed Tomography: 1. Effect of Object Size , 1979, Journal of computer assisted tomography.
[49] J. Links,et al. Assessment of dopamine receptor densities in the human brain with carbon‐11‐labeled N‐methylspiperone , 1984, Annals of neurology.
[50] Stefano Zamuner,et al. Prediction of Repeat-Dose Occupancy from Single-Dose Data: Characterisation of the Relationship between Plasma Pharmacokinetics and Brain Target Occupancy , 2011, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[51] R. Parsey,et al. Binding to Metabotropic Glutamate Receptor Subtype 5 , 2014 .
[52] T Jones,et al. In vivo disturbance of the oxidative metabolism of glucose in human cerebral gliomas , 1983, Annals of neurology.
[53] Susan P. Hume,et al. Quantification of PET studies with the high affinity D2/D3 receptor ligand [C-11]FLB-457: Re-evaluation of the validity of using a cerebellar reference region , 2005 .
[54] Charles F. Reynolds,et al. Reduced binding of [ 18 F ]altanserin to serotonin type 2A receptors in aging: persistence of effect after partial volume correction , 1998, Brain Research.
[55] Sébastien Ourselin,et al. Markov random field and Gaussian mixture for segmented MRI-based partial volume correction in PET , 2012, Physics in medicine and biology.
[56] Nathalie Ginovart,et al. Imaging the Dopamine System with In Vivo [11C]raclopride Displacement Studies: Understanding the True Mechanism , 2005, Molecular Imaging and Biology.
[57] Anil Kumar,et al. Characterization of [11C]RO5013853, a novel PET tracer for the glycine transporter type 1 (GlyT1) in humans , 2013, NeuroImage.
[58] E. M. Renkin. Effects of blood flow on diffusion kinetics in isolated, perfused hindlegs of cats; a double circulation hypothesis. , 1955, The American journal of physiology.
[59] Joanna L. Sharman,et al. IUPHAR-DB: updated database content and new features , 2012, Nucleic Acids Res..
[60] Claudia Kuntner,et al. Quantitative preclinical PET imaging: opportunities and challenges , 2014, Front. Physics.
[61] L. Rajendran,et al. Subcellular targeting strategies for drug design and delivery , 2010, Nature Reviews Drug Discovery.
[62] J. Hatazawa,et al. 6-[18F]Fluorodopa metabolism in patients with hemiparkinsonism studied by positron emission tomography , 1993, Journal of the Neurological Sciences.
[63] W. Klunk,et al. Imaging Tau Deposits In Vivo: Progress in Viewing More of The Proteopathy Picture , 2013, Neuron.
[64] Peter C. Searson,et al. The blood-brain barrier: an engineering perspective , 2013, Front. Neuroeng..
[65] R. Bellman,et al. On structural identifiability , 1970 .
[66] Stina Syvänen,et al. Predicting brain concentrations of drug using positron emission tomography and venous input: modeling of arterial-venous concentration differences , 2006, European Journal of Clinical Pharmacology.
[67] R. Myers,et al. Quantitation of Carbon‐11‐labeled raclopride in rat striatum using positron emission tomography , 1992, Synapse.
[68] John D. Beaver,et al. PET imaging of dopamine D3 receptors in humans with [11C]-(+)-PHNO: dissection of PHNO signal using two highly selective D3 antagonists , 2010, NeuroImage.
[69] R P Williams,et al. Noninvasive grading of musculoskeletal tumors using PET. , 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[70] Making drug development visible--and viable. , 2014, Drug discovery today.
[71] Paul Edison,et al. Reference Region Automatic Extraction in Dynamic [11C]PIB , 2013, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[72] Albert Gjedde,et al. Subchronic Haloperidol Downregulates Dopamine Synthesis Capacity in the Brain of Schizophrenic Patients In Vivo , 2003, Neuropsychopharmacology.
[73] C. Halldin,et al. Test–retest reliability of [11C]AZ10419369 binding to 5-HT1B receptors in human brain , 2014, European Journal of Nuclear Medicine and Molecular Imaging.
[74] B. Ruggeri,et al. Animal models of human disease: challenges in enabling translation. , 2014, Biochemical pharmacology.
[75] S. DeKosky,et al. Simplified quantification of Pittsburgh Compound B amyloid imaging PET studies: a comparative analysis. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[76] H. Watabe,et al. Validation of noninvasive quantification of rCBF compared with dynamic/integral method by using positron emission tomography and oxygen-15 labeled water , 1995, Annals of nuclear medicine.
[77] Andrew B. Lawson,et al. Spatial cluster modelling , 2002 .
[78] Patrick W. Stroman,et al. Spatial normalization, bulk motion correction and coregistration for functional magnetic resonance imaging of the human cervical spinal cord and brainstem. , 2008, Magnetic resonance imaging.
[79] Peter Herscovitch,et al. Correction of Positron Emission Tomography Data for Cerebral Atrophy , 1986, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[80] Karmen K. Yoder,et al. ntPET: A New Application of PET Imaging for Characterizing the Kinetics of Endogenous Neurotransmitter Release , 2005 .
[81] R. Parsey,et al. In Vivo Ketamine-Induced Changes in [11C]ABP688 Binding to Metabotropic Glutamate Receptor Subtype 5 , 2015, Biological Psychiatry.
[82] John Ashburner,et al. Quantitation of [11C]diprenorphine cerebral kinetics in man acquired by PET using presaturation, pulse-chase and tracer-only protocols , 1994, Journal of Neuroscience Methods.
[83] Christopher C Rowe,et al. Tau imaging: early progress and future directions , 2015, The Lancet Neurology.
[84] Bruce R. Rosen,et al. Cortical surface-based analysis reduces bias and variance in kinetic modeling of brain PET data , 2014, NeuroImage.
[85] Mark Slifstein,et al. Translational characterization of [11C]GSK931145, a PET ligand for the glycine transporter type 1 , 2011, Synapse.
[86] Arthur W. Toga,et al. Investigation of partial volume correction methods for brain FDG PET studies , 1996 .
[87] W C Eckelman,et al. Quantification of Amphetamine-Induced Changes in [11C]Raclopride Binding with Continuous Infusion , 1997, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[88] V. Ikonomidou,et al. Translocator Protein PET Imaging for Glial Activation in Multiple Sclerosis , 2011, Journal of Neuroimmune Pharmacology.
[89] G. Alexander,et al. Characterization of the image-derived carotid artery input function using independent component analysis for the quantitation of [18F] fluorodeoxyglucose positron emission tomography images , 2007, Physics in medicine and biology.
[90] Francis J McMahon,et al. In vivo radioligand binding to translocator protein correlates with severity of Alzheimer's disease. , 2013, Brain : a journal of neurology.
[91] Marie-Claude Asselin,et al. Quantification of PET Studies with the Very High-Affinity Dopamine D2/D3 Receptor Ligand [11C]FLB 457: Re-Evaluation of the Validity of using a Cerebellar Reference Region , 2007, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[92] Julie C Price,et al. Age, Sex, and Reproductive Hormone Effects on Brain Serotonin-1A and Serotonin-2A Receptor Binding in a Healthy Population , 2011, Neuropsychopharmacology.
[93] M E Phelps,et al. Quantitation in Positron Emission Computed Tomography: 3. Effect of Sampling , 1980, Journal of computer assisted tomography.
[94] Mark Jenkinson,et al. Imaging dopamine receptors in humans with [11C]-(+)-PHNO: Dissection of D3 signal and anatomy , 2011, NeuroImage.
[95] Zsolt Szabo,et al. Positron emission tomography imaging of serotonin transporters in the human brain using [11C](+)McN5652 , 1995, Synapse.
[96] A Malizia,et al. First delineation of 5-HT1A receptors in human brain with PET and [11C]WAY-100635. , 1995, European journal of pharmacology.
[97] Min-Ying Su,et al. Early clinical PET imaging results with the novel PHF-tau radioligand [F18]-T808. , 2014, Journal of Alzheimer's disease : JAD.
[98] Sylvain Houle,et al. Effects of aging on 5‐HT2AR binding: a HRRT PET study with and without partial volume corrections , 2011, International journal of geriatric psychiatry.
[99] M. Laruelle,et al. Imaging the D3 receptor in humans in vivo using [11C](+)-PHNO positron emission tomography (PET). , 2010, The international journal of neuropsychopharmacology.
[100] Roger N Gunn,et al. An 18-kDa Translocator Protein (TSPO) polymorphism explains differences in binding affinity of the PET radioligand PBR28 , 2011, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[101] Elizabeth Head,et al. Fibril specific, conformation dependent antibodies recognize a generic epitope common to amyloid fibrils and fibrillar oligomers that is absent in prefibrillar oligomers , 2007, Molecular Neurodegeneration.
[102] Ronald Boellaard,et al. Optimization of supervised cluster analysis for extracting reference tissue input curves in (R)-[11C]PK11195 brain PET studies , 2012, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[103] S. DeKosky,et al. Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease , 2008, Brain : a journal of neurology.
[104] Alan A. Wilson,et al. Quantification of Human Opiate Receptor Concentration and Affinity Using High and Low Specific Activity [11C]Diprenorphine and Positron Emission Tomography , 1991, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[105] Olivier Salvado,et al. MR-Less High Dimensional Spatial Normalization of 11C PiB PET Images on a Population of Elderly, Mild Cognitive Impaired and Alzheimer Disease Patients , 2008, MICCAI.
[106] Marc Laruelle,et al. The role of in vivo molecular imaging with PET and SPECT in the elucidation of psychiatric drug action and new drug development , 2002, European Neuropsychopharmacology.
[107] D E Kuhl,et al. Compartmental Analysis of [11C]Flumazenil Kinetics for the Estimation of Ligand Transport Rate and Receptor Distribution Using Positron Emission Tomography , 1991, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[108] Marc Laruelle,et al. Within-Subject Comparison of [11C]-( + )-PHNO and [11C]raclopride Sensitivity to Acute Amphetamine Challenge in Healthy Humans , 2012, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[109] Robert B. Innis,et al. Mixed-Affinity Binding in Humans with 18-kDa Translocator Protein Ligands , 2011, The Journal of Nuclear Medicine.
[110] Kenneth A Krohn,et al. Interpreting enzyme and receptor kinetics: keeping it simple, but not too simple. , 2003, Nuclear medicine and biology.
[111] J. Melichar,et al. Benzodiazepine dependence and its treatment with low dose flumazenil , 2014, British journal of clinical pharmacology.
[112] N. Volkow,et al. Imaging the norepinephrine transporter in humans with (S,S)-[11C]O-methyl reboxetine and PET: problems and progress. , 2007, Nuclear medicine and biology.
[113] Mark Slifstein,et al. Revisiting an Old Issue: The Discrepancy Between Tissue Ratio–Derived Binding Parameters and Kinetic Modeling–Derived Parameters After a Bolus of the Serotonin Transporter Radioligand 123I-ADAM , 2008, Journal of Nuclear Medicine.
[114] Stephen M. Smith,et al. Segmentation of brain MR images through a hidden Markov random field model and the expectation-maximization algorithm , 2001, IEEE Transactions on Medical Imaging.
[115] Mark Slifstein,et al. Impact of D2 Receptor Internalization on Binding Affinity of Neuroimaging Radiotracers , 2010, Neuropsychopharmacology.
[116] Yuan-Hwa Chou,et al. [(11)C]PE2I: a highly selective radioligand for PET examination of the dopamine transporter in monkey and human brain. , 2003, European journal of nuclear medicine and molecular imaging.
[117] C. Crone,et al. THE PERMEABILITY OF CAPILLARIES IN VARIOUS ORGANS AS DETERMINED BY USE OF THE 'INDICATOR DIFFUSION' METHOD. , 1963, Acta physiologica Scandinavica.
[118] Kenneth Levenberg. A METHOD FOR THE SOLUTION OF CERTAIN NON – LINEAR PROBLEMS IN LEAST SQUARES , 1944 .
[119] Roger N Gunn,et al. Quantification of the Specific Translocator Protein Signal of 18F-PBR111 in Healthy Humans: A Genetic Polymorphism Effect on In Vivo Binding , 2013, The Journal of Nuclear Medicine.
[120] Robert B. Innis,et al. Strategies to Improve Neuroreceptor Parameter Estimation by Linear Regression Analysis , 2002, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[121] J. Krystal,et al. Increased striatal dopamine transmission in schizophrenia: confirmation in a second cohort. , 1998, The American journal of psychiatry.
[122] Jennifer M. Coughlin,et al. Regional brain distribution of translocator protein using [11C]DPA-713 PET in individuals infected with HIV , 2014, Journal of NeuroVirology.
[123] Stephen M Smith,et al. Fast robust automated brain extraction , 2002, Human brain mapping.
[124] P. Cumming,et al. PET radiopharmaceuticals for probing enzymes in the brain. , 2013, American journal of nuclear medicine and molecular imaging.
[125] Yuan-Hwa Chou,et al. [11C]PE2I: a highly selective radioligand for PET examination of the dopamine transporter in monkey and human brain , 2003, European Journal of Nuclear Medicine and Molecular Imaging.
[126] Ralph Myers,et al. Assessment of Spatial Normalization of PET Ligand Images Using Ligand-Specific Templates , 1999, NeuroImage.
[127] P. Follesa,et al. Flumazenil selectively prevents the increase in α4‐subunit gene expression and an associated change in GABAA receptor function induced by ethanol withdrawal , 2007, Journal of neurochemistry.
[128] Guobao Wang,et al. Direct reconstruction of dynamic PET parametric images using sparse spectral representation , 2009, 2009 IEEE International Symposium on Biomedical Imaging: From Nano to Macro.
[129] C S Patlak,et al. Graphical Evaluation of Blood-to-Brain Transfer Constants from Multiple-Time Uptake Data , 1983, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[130] Jeih-San Liow,et al. Linearized Reference Tissue Parametric Imaging Methods: Application to [11C]DASB Positron Emission Tomography Studies of the Serotonin Transporter in Human Brain , 2003, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[131] R. Narendran,et al. Decreased Vesicular Monoamine Transporter Type 2 Availability in the Striatum Following Chronic Cocaine Self-Administration in Nonhuman Primates , 2015, Biological Psychiatry.
[132] C Crouzel,et al. Quantification of Benzodiazepine Receptors in Human Brain Using PET, [11C]Flumazenil, and a Single-Experiment Protocol , 1995, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[133] R. Boellaard,et al. Test-retest variability of quantitative [11C]PIB studies in Alzheimer’s disease , 2009, European Journal of Nuclear Medicine and Molecular Imaging.
[134] Richard E Carson,et al. Cerebral blood flow with [15O]water PET studies using an image-derived input function and MR-defined carotid centerlines , 2013, Physics in medicine and biology.
[135] Lutz Tellmann,et al. Image-derived input function obtained in a 3TMR-brainPET , 2013 .
[136] J. Ashburner,et al. Nonlinear spatial normalization using basis functions , 1999, Human brain mapping.
[137] N. Volkow,et al. Distribution Volume Ratios without Blood Sampling from Graphical Analysis of PET Data , 1996, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[138] H. Mayberg,et al. Correction of PET Data for Partial Volume Effects in Human Cerebral Cortex by MR Imaging , 1990, Journal of computer assisted tomography.
[139] G. Sedvall,et al. An open label trial of raclopride in acute schizophrenia. Confirmation of D2-dopamine receptor occupancy by PET , 2004, Psychopharmacology.
[140] Gwenn S. Smith,et al. Analyses of [18F]altanserin bolus injection PET data. II: Consideration of radiolabeled metabolites in humans , 2001, Synapse.
[141] C. Halldin,et al. PET imaging of central 5-HT2A receptors with carbon-11-MDL 100,907. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[142] C. Jack,et al. Application of the National Institute on Aging–Alzheimer’s Association AD criteria to ADNI , 2013, Neurology.
[143] Majaz Moonis,et al. Amyloid Deposition Begins in the Striatum of Presenilin-1 Mutation Carriers from Two Unrelated Pedigrees , 2007, The Journal of Neuroscience.
[144] M. Laruelle,et al. Unexpectedly high affinity of a novel histamine H3 receptor antagonist, GSK239512, in vivo in human brain, determined using PET , 2014, British journal of pharmacology.
[145] I. Buvat,et al. A review of partial volume correction techniques for emission tomography and their applications in neurology, cardiology and oncology , 2012, Physics in medicine and biology.
[146] W. Klunk,et al. Development of positron emission tomography β-amyloid plaque imaging agents. , 2012, Seminars in nuclear medicine.
[147] M Laruelle,et al. Alterations of benzodiazepine receptors in type II alcoholic subjects measured with SPECT and [123I]iomazenil. , 1998, The American journal of psychiatry.
[148] Robert B. Innis,et al. SPECT Quantification of [123I]Iomazenil Binding to Benzodiazepine Receptors in Nonhuman Primates: II. Equilibrium Analysis of Constant Infusion Experiments and Correlation with in vitro Parameters , 1994, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[149] A. Rehemtulla,et al. Molecular Imaging , 2009, Methods in Molecular Biology.
[150] Karl J. Friston,et al. Spatial normalization of lesioned brains: Performance evaluation and impact on fMRI analyses , 2007, NeuroImage.
[151] Michael Kassiou,et al. The Translocator Protein , 2011, The Journal of Nuclear Medicine.
[152] Kjell Någren,et al. Measurement of Serotonin 5-HT1A Receptor Binding Using Positron Emission Tomography and [carbonyl-11C]WAY-100635—Considerations on the Validity of Cerebellum as a Reference Region , 2007 .
[153] T. Jones,et al. Parametric image reconstruction using spectral analysis of PET projection data. , 1998, Physics in medicine and biology.
[154] R. P. Maguire,et al. Consensus Nomenclature for in vivo Imaging of Reversibly Binding Radioligands , 2007, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[155] P. Piccini. Dopamine transporter: Basic aspects and neuroimaging , 2003, Movement disorders : official journal of the Movement Disorder Society.
[156] Kazuhiko Yanai,et al. Tau PET Imaging in Alzheimer’s Disease , 2014, Current Neurology and Neuroscience Reports.
[157] Patrick L. McGeer,et al. Molecular Neurobiology of the Mammalian Brain , 1978, Springer US.
[158] Lutz Tellmann,et al. MR-Based PET Motion Correction Procedure for Simultaneous MR-PET Neuroimaging of Human Brain , 2012, PloS one.
[159] B. Lopresti,et al. Implementation and performance of an optical motion tracking system for high resolution brain PET imaging , 1998, 1998 IEEE Nuclear Science Symposium Conference Record. 1998 IEEE Nuclear Science Symposium and Medical Imaging Conference (Cat. No.98CH36255).
[160] A. Lammertsma,et al. Simplified Reference Tissue Model for PET Receptor Studies , 1996, NeuroImage.
[161] Moors Pieter,et al. Test-retest reliability. , 2014 .
[162] Roger N. Gunn,et al. Tracer Kinetic Modeling of the 5-HT1AReceptor Ligand [carbonyl-11C]WAY-100635 for PET , 1998, NeuroImage.
[163] S. Kapur,et al. Phosphodiesterase 10A PET Radioligand Development Program: From Pig to Human , 2014, The Journal of Nuclear Medicine.
[164] M. Modat,et al. The importance of appropriate partial volume correction for PET quantification in Alzheimer’s disease , 2011, European Journal of Nuclear Medicine and Molecular Imaging.
[165] H R Schelbert,et al. Blood flow and metabolism by PET. , 1994, Cardiology clinics.
[166] D. Nutt,et al. Imaging Endogenous Opioid Peptide Release with [11C]Carfentanil and [3H]Diprenorphine: Influence of Agonist-Induced Internalization , 2014, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[167] J. Mazziotta,et al. PET imaging of neuropathology in tauopathies: progressive supranuclear palsy. , 2013, Journal of Alzheimer's disease : JAD.
[168] D. Nutt,et al. Influence of agonist induced internalization on [3H]Ro15‐4513 binding—an application to imaging fluctuations in endogenous GABA with positron emission tomography , 2015, Synapse.
[169] Roger N. Gunn,et al. Pharmacological constraints associated with positron emission tomographic scanning of small laboratory animals , 1998, European Journal of Nuclear Medicine.
[170] P. Grasby,et al. Characterisation of the appearance of radioactive metabolites in monkey and human plasma from the 5-HT1A receptor radioligand, [carbonyl-11C]WAY-100635--explanation of high signal contrast in PET and an aid to biomathematical modelling. , 1998, Nuclear medicine and biology.
[171] W. Birkfellner,et al. Application of image-derived and venous input functions in major depression using [carbonyl-(11)C]WAY-100635. , 2013, Nuclear medicine and biology.
[172] Peter Herscovitch,et al. Comparison of Bolus and Infusion Methods for Receptor Quantitation: Application to [18F]Cyclofoxy and Positron Emission Tomography , 1993, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[173] F Fazio,et al. Importance of partial-volume correction in brain PET studies. , 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[174] M. Mintun,et al. A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography , 1984, Annals of neurology.
[175] Nick C Fox,et al. 11C-PiB PET assessment of change in fibrillar amyloid-β load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study , 2010, The Lancet Neurology.
[176] Elliot A Stein,et al. Greater Nicotinic Acetylcholine Receptor Density in Smokers Than in Nonsmokers: A PET Study with 2-18F-FA-85380 , 2008, Journal of Nuclear Medicine.
[177] Mark Slifstein,et al. Monoamine Transporter Occupancy of a Novel Triple Reuptake Inhibitor in Baboons and Humans Using Positron Emission Tomography Clinical Imaging , 2022 .
[178] Paolo Zanotti-Fregonara,et al. Kinetic analysis of [11C]befloxatone in the human brain, a selective radioligand to image monoamine oxidase A , 2013, EJNMMI Research.
[179] W. Klunk,et al. Positron emission tomography radioligands for in vivo imaging of Aβ plaques. , 2013, Journal of labelled compounds & radiopharmaceuticals.
[180] C. Masters,et al. The challenges of tau imaging , 2012 .
[181] J. Hirvonen,et al. Increased In Vivo Expression of an Inflammatory Marker in Temporal Lobe Epilepsy , 2012, The Journal of Nuclear Medicine.
[182] M. Laruelle,et al. Dopamine as the wind of the psychotic fire: new evidence from brain imaging studies , 1999, Journal of psychopharmacology.
[183] Yu-Shin Ding,et al. PET imaging of norepinephrine transporters. , 2006, Current pharmaceutical design.
[184] E. W. EMERY,et al. Compartmental Analysis , 1970, Nature.
[185] Rainer E. Martin,et al. G protein-coupled receptor transmembrane binding pockets and their applications in GPCR research and drug discovery: a survey. , 2011, Current topics in medicinal chemistry.
[186] Vincent Doré,et al. In vivo evaluation of a novel tau imaging tracer for Alzheimer’s disease , 2014, European Journal of Nuclear Medicine and Molecular Imaging.
[187] R. Millar,et al. The year in G protein-coupled receptor research. , 2010, Molecular endocrinology.
[188] C. Halldin,et al. Quantitative analyses of carbonyl-carbon-11-WAY-100635 binding to central 5-hydroxytryptamine-1A receptors in man. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[189] Agneta Nordberg,et al. Nicotinic receptor abnormalities of Alzheimer’s disease: therapeutic implications , 2001, Biological Psychiatry.
[190] E. Hoffman,et al. Quantitation in positron emission computed tomography: 2. Effects of inaccurate attenuation correction. , 1979, Journal of computer assisted tomography.
[191] Michael Brady,et al. A Biomathematical Modeling Approach to Central Nervous System Radioligand Discovery and Development , 2009, Journal of Nuclear Medicine.
[192] D. Feng,et al. Noninvasive Quantification of the Cerebral Metabolic Rate for Glucose Using Positron Emission Tomography, 18F-Fluoro-2-Deoxyglucose, the Patlak Method, and an Image-Derived Input Function , 1998, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[193] Jerry L Prince,et al. Measurement of Radiotracer Concentration in Brain Gray Matter Using Positron Emission Tomography: MRI-Based Correction for Partial Volume Effects , 1992, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[194] S. Kety. The theory and applications of the exchange of inert gas at the lungs and tissues. , 1951, Pharmacological reviews.
[195] Philip J. Noonan,et al. The design and initial calibration of an optical tracking system using the Microsoft Kinect , 2011, 2011 IEEE Nuclear Science Symposium Conference Record.
[196] Lisa A. Weissfeld,et al. Assessment of parameter settings for SPM5 spatial normalization of structural MRI data: Application to type 2 diabetes , 2008, NeuroImage.
[197] Alessandro Sardini,et al. Agonist‐dependent internalization of D2 receptors: Imaging quantification by confocal microscopy , 2007, Synapse.
[198] H. Akaike. A new look at the statistical model identification , 1974 .
[199] R B Banati,et al. In vivo visualization of activated glia by [11C] (R)-PK11195-PET following herpes encephalitis reveals projected neuronal damage beyond the primary focal lesion. , 2001, Brain : a journal of neurology.
[200] Claus Svarer,et al. Cerebral serotonin transporter binding is inversely related to body mass index , 2010, NeuroImage.
[201] Rajendra D. Badgaiyan,et al. A novel method for noninvasive detection of neuromodulatory changes in specific neurotransmitter systems , 2003, NeuroImage.
[202] S. Stone-Elander,et al. Stereoselective binding of 11C-raclopride in living human brain — a search for extrastriatal central D2-dopamine receptors by PET , 2004, Psychopharmacology.
[203] M. Laruelle. Imaging Synaptic Neurotransmission with in Vivo Binding Competition Techniques: A Critical Review , 2000, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[204] Arthur Christopoulos,et al. Emerging paradigms in GPCR allostery: implications for drug discovery , 2013, Nature Reviews Drug Discovery.
[205] Z. Bhagwagar,et al. Age Effects on Serotonin Receptor 1B as Assessed by PET , 2012, The Journal of Nuclear Medicine.
[206] J. Trojanowski,et al. Imaging of Tau Pathology in a Tauopathy Mouse Model and in Alzheimer Patients Compared to Normal Controls , 2013, Neuron.
[207] R. Zipursky,et al. PET and SPECT Imaging in Psychiatric Disorders , 2007, Canadian journal of psychiatry. Revue canadienne de psychiatrie.
[208] D E Kuhl,et al. Dual-[11C]Tracer Single-Acquisition Positron Emission Tomography Studies , 2001, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[209] Wufan Chen,et al. 3.5D dynamic PET image reconstruction incorporating kinetics-based clusters , 2012, Physics in medicine and biology.
[210] André Luxen,et al. PET radiotracers for molecular imaging in the brain: Past, present and future , 2012, NeuroImage.
[211] Mark Slifstein,et al. Estimation of serotonin transporter parameters with 11C-DASB in healthy humans: reproducibility and comparison of methods. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[212] François Mauguière,et al. Seizure-related short-term plasticity of benzodiazepine receptors in partial epilepsy: a [11C]flumazenil-PET study. , 2005, Brain : a journal of neurology.
[213] J. Levin. Emission Tomographic Studies in Substance Abuse , 2001 .
[214] El Mostafa Fadaili,et al. Comparison of Eight Methods for the Estimation of the Image-Derived Input Function in Dynamic [18F]-FDG PET Human Brain Studies , 2009, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[215] Kjell Någren,et al. Measurement of central µ-opioid receptor binding in vivo with PET and [11C]carfentanil: a test–retest study in healthy subjects , 2009, European Journal of Nuclear Medicine and Molecular Imaging.
[216] Masahiro Fujita,et al. Comparison of [11C]-(R)-PK 11195 and [11C]PBR28, two radioligands for translocator protein (18 kDa) in human and monkey: Implications for positron emission tomographic imaging of this inflammation biomarker , 2010, NeuroImage.
[217] G. Alexander,et al. Fibrillar amyloid-β burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease , 2009, Proceedings of the National Academy of Sciences.
[218] Alan A. Wilson,et al. Evaluation of 11C-GSK189254 as a Novel Radioligand for the H3 Receptor in Humans Using PET , 2010, Journal of Nuclear Medicine.
[219] Patrick Dupont,et al. [18F]MK-9470, a positron emission tomography (PET) tracer for in vivo human PET brain imaging of the cannabinoid-1 receptor , 2007, Proceedings of the National Academy of Sciences.
[220] N. Volkow,et al. BMI Modulates Calorie-Dependent Dopamine Changes in Accumbens from Glucose Intake , 2014, PloS one.
[221] J J DiStefano,et al. Multiexponential, multicompartmental, and noncompartmental modeling. II. Data analysis and statistical considerations. , 1984, The American journal of physiology.
[222] Mark Slifstein,et al. Relationships between radiotracer properties and image quality in molecular imaging of the brain with positron emission tomography. , 2003, Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging.
[223] Alan A. Wilson,et al. Imaging Dopamine D3 Receptors in the Human Brain with Positron Emission Tomography, [11C]PHNO, and a Selective D3 Receptor Antagonist , 2010, Biological Psychiatry.
[224] C Crouzel,et al. PET study of carbon-11-PK 11195 binding to peripheral type benzodiazepine sites in glioblastoma: a case report. , 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[225] Vladimir Kepe,et al. PET scanning of brain tau in retired national football league players: preliminary findings. , 2013, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.
[226] A. Evans,et al. Correction for partial volume effects in PET: principle and validation. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[227] Mark Slifstein,et al. Measuring Drug Occupancy in the Absence of a Reference Region: The Lassen Plot Re-Visited , 2010, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[228] P. Morgan,et al. The Cubic Ternary Complex ReceptorOccupancy Model I. Model Description , 1996 .
[229] Jinsong Ouyang,et al. MR-based motion correction for PET imaging using wired active MR microcoils in simultaneous PET-MR: phantom study. , 2014, Medical physics.
[230] Ronald J. Jaszczak,et al. Bayesian reconstruction and use of anatomical a priori information for emission tomography , 1996, IEEE Trans. Medical Imaging.
[231] P. Grasby,et al. Evaluation of EMD 128 130 occupancy of the 5-HT1A and the D2 receptor: a human PET study with [11]WAY-100635 and [11C]raclopride , 2002, Journal of psychopharmacology.
[232] M N Cantwell,et al. Does cerebral blood flow decline in healthy aging? A PET study with partial-volume correction. , 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[233] J. Kehler,et al. PDE10A inhibitors: novel therapeutic drugs for schizophrenia. , 2011, Current pharmaceutical design.
[234] William J. Jagust,et al. Automated template-based PET region of interest analyses in the aging brain , 2007, NeuroImage.
[235] W. L. Chiou,et al. The Phenomenon and Rationale of Marked Dependence of Drug Concentration on Blood Sampling Site , 1989, Clinical pharmacokinetics.
[236] Jeih-San Liow,et al. Design of a motion-compensation OSEM list-mode algorithm for resolution-recovery reconstruction for the HRRT , 2003, 2003 IEEE Nuclear Science Symposium. Conference Record (IEEE Cat. No.03CH37515).
[237] A. Rahmim,et al. Direct 4D reconstruction of parametric images incorporating anato-functional joint entropy , 2010, 2008 IEEE Nuclear Science Symposium Conference Record.
[238] Alan A. Wilson,et al. Imaging the serotonin transporter with positron emission tomography: initial human studies with [11C]DAPP and [11C]DASB , 2000, European Journal of Nuclear Medicine.
[239] R. Lefkowitz,et al. A ternary complex model explains the agonist-specific binding properties of the adenylate cyclase-coupled beta-adrenergic receptor. , 1980, The Journal of biological chemistry.
[240] L. Iversen,et al. Neurotransmitter transporters and their impact on the development of psychopharmacology , 2006, British journal of pharmacology.
[241] Arthur Christopoulos,et al. Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders , 2009, Nature Reviews Drug Discovery.
[242] W. Gordon Frankle,et al. [11C]flumazenil Binding Is Increased in a Dose-Dependent Manner with Tiagabine-Induced Elevations in GABA Levels , 2012, PloS one.
[243] Andrew S. Felts,et al. Relationship between In Vivo Receptor Occupancy and Efficacy of Metabotropic Glutamate Receptor Subtype 5 Allosteric Modulators with Different In Vitro Binding Profiles , 2015, Neuropsychopharmacology.
[244] Christer Halldin,et al. Positron emission tomography imaging of 5-hydroxytryptamine1B receptors in Parkinson's disease , 2014, Neurobiology of Aging.